As expected, tumor growth inhibition was proportional to Daxx downregulation in both human-derived tumor xenografts (Fig. 7a) and mouse-derived syngeneic tumor grafts (Fig. 7b), suggesting that Daxx downregulation serves as a key strategy to enhance oncolysis in murine tumors. The gene discussed is DAXX; the disease is neoplasm.